With the world gripped in a bout of anxiety over the Wuhan coronavirus one way we have been grounded by the crisis is when Hollywood has been affected because <sarc> they are this society’s betters and are actually America’s royalty.</sarc.>
We all were equally affected last week when it was announced that Tom Hanks and his actress wife had both contracted The Wuhan. Now as more stories come rolling in we learn that one other major name has been targeted — James Bond!
With our society essentially becoming a sprawling shuttered neighborhood one industry feeling the impact has been Hollywood. Ahead of an expected downturn in the marketplace, a number of big-name titles have been removed from the release schedule by the studios. One of those has been the latest in the 007 franchise.
MGM, Universal and Bond producers, Michael G. Wilson and Barbara Broccoli, announced today that after careful consideration and thorough evaluation of the global theatrical marketplace, the release of NO TIME TO DIE will be postponed until November 2020. pic.twitter.com/a9h1RP5OKd
— James Bond (@007) March 4, 2020
This will be an ongoing challenge, as titles taken from the schedule need to find dates on an already populated calendar.
But in addition to the outbreak pushing the movie aside, there was a more direct threat reported. One of the actors who has been looked at as the heir apparent following Daniel Craig for the James Bond role has been Idris Elba. While that possibility remains in the balance some more dire news has arrived.
This morning I tested positive for Covid 19. I feel ok, I have no symptoms so far but have been isolated since I found out about my possible exposure to the virus. Stay home people and be pragmatic. I will keep you updated on how I’m doing ???? No panic. pic.twitter.com/Lg7HVMZglZ
— Idris Elba (@idriselba) March 16, 2020
This is starting to appear like an oddly specific targeting by this virus! We closing down now and heading over to the Sean Connery account RIGHT NOW!
To change your comments display name, click here.